Takeda acquires license to ALS therapy aimed at toxic TDP-43
Takeda acquires license to ALS therapy aimed at toxic TDP-43
Takeda acquires license to ALS therapy aimed at toxic TDP-43 protein | AS-202 designed to block enzyme with role in TDP-43 buildup | ALS News Today Just a moment... a new drug . . . ! ? :hug: |
All times are GMT -5. The time now is 03:15 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.